Rapid Respiratory Panel Testing for SARS-CoV-2: Experience in a Private Tertiary Hospital
Keywords:COVID-19, SARS-CoV-2, diagnostics, film array, RT-PCR
SARS-CoV-2 has infected more than 643 million individuals worldwide and accounts for close to 64,950 deaths in the Philippines. Due to COVID-19’s clinical overlap with other diseases and non-specific radiologic findings, its diagnosis rests primarily on laboratory methods, including reverse transcription polymerase chain reaction (RT-PCR) and multiplexed molecular platforms for rapid syndromic testing. Compared to RT-PCR which has a turnaround time of 24 to 72 hours, multiplexed molecular platforms can provide alternative diagnoses to COVID-19 in an average of one hour, providing meaningful data that can impact clinical and resource management when handling acute surge of patients with respiratory symptoms.
Download data is not yet available.
How to Cite
Tamayo, S. C., Andal, J. J., Madrid, M., Lagamayo, E., Lo, R., & Ang, D. (2023). Rapid Respiratory Panel Testing for SARS-CoV-2: Experience in a Private Tertiary Hospital. PJP, 7(2), 50–53. https://doi.org/10.21141/10.21141/PJP.2022.18
The Philippine Journal of Pathology is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Based on works made open access at http://philippinejournalofpathology.org